Researchers Explore Precision Fermentation for Animal-Free Egg Proteins

Scientists at Cranfield University and startup HyphaPro are investigating whether filamentous fungi can produce ovotransferrin via precision fermentation. The egg white protein binds iron and has antimicrobial properties, offering a potential animal-free alternative less vulnerable to bird flu disruptions.

Researchers at Cranfield University are collaborating with Exeter startup HyphaPro to investigate whether engineered filamentous fungi can produce ovotransferrin through precision fermentation. At the same time, market research from Future Market Insights projects the global animal-free egg protein market to reach USD 1,933.5 million by 2036. Cranfield University Project According to Cultivated X, Dr Abhishek Baghela leads the Cranfield project with support from Lecturer Dr Carla Cervini. The research takes place at the university's Magan Centre of Applied Mycology. Cranfield set up this centre with £7.2 million from Research England's Expanding Excellence in England fund. HyphaPro director Dr Andrew J. Foster acts as the industry partner for the project. The team will grow specially engineered fungal strains in controlled tanks. They want to test whether these strains can produce ovotransferrin, an egg white protein that binds iron and has antimicrobial properties. Hen eggs currently supply this protein, which is used in functional foods and dietary supplements. Cultivated X states that this reliance leaves supply exposed to environmental pressures, rising costs, and bird flu outbreaks. The project aims to create a proof-of-concept production process that can later be scaled up commercially. If successful, the method could extend to other high-value proteins. The National Alternative Protein Innovation Centre funded the project. In September, the centre awarded more than £1 million to 33 collaborative projects in its second round of Collaborative Programme Funding, which included HyphaPro and Baghela's group. Cultivated X notes that the specific project timeline and the exact value of this individual grant have not been disclosed. HyphaPro opened its first laboratory at Exeter Science Park in January. The company has worked on fungal production of both ovotransferrin and ovalbumin. Dr Baghela stated that the team aims to demonstrate the potential of fungal precision fermentation to manufacture high-value functional ingredients. Dr Andrew J. Foster is not quoted in the text. Most advanced companies in precision-fermented egg proteins have focused on ovalbumin, the main protein in egg white. Because ovotransferrin serves a different set of products like functional foods and supplements, the Cranfield project tests whether fungal fermentation can supply this second egg protein. Market Projections According to Finanznachrichten, the global animal-free egg protein market was valued at USD 237.5 million in 2025. It is projected to reach USD 287.4 million in 2026. The sector is expected to expand rapidly to USD 1,933.5 million by 2036, advancing at a compound annual growth rate of 21.0% over the forecast period from 2026 to 2036. Financialachrichten reports that the leading type segment in 2026 is precision-fermented ovalbumin with a 56.1% share. The leading form segment in 2026 is liquid with a 56.1% share. The leading application in 2026 is bakery, accounting for a 38.0% share. The fastest-growing country is Singapore with a 26.3% compound annual growth rate. The second fastest-growing country is the Netherlands with a 25.3% compound annual growth rate. Finanznachrichten states that industrial food companies are replacing traditional egg products with plant-based and precision-fermented alternatives to ensure recipe repeatability and mitigate extreme supply chain vulnerabilities. Three critical factors drive this market expansion. These are poultry disease cycles and supply volatility, precision fermentation standardization, and functional consistency across batches. Finanznachrichten notes that recent avian-influenza waves reported by the United States Department of Agriculture Economic Research Service saw 50.7 million egg-laying hens depopulated. Nandini Roy Choudhury, principal analyst at Future Market Insights, stated that commercial confidence will depend on repeatable performance at customer production scale under local compliance requirements. Choudhury also stated that manufacturers should test each alternative against the exact egg function that controls finished product quality during routine production. Precision-fermented ovalbumin delivers standardized protein behavior identical to egg white ovalbumin, broad recipe compatibility in savory sauce, confectionery, and bakery applications, and dosage control that allows precise industrial formulation and predictable production yields. The liquid format streamlines back-of-house operations for commercial kitchens and manufacturing plants by removing hydration steps, preventing dosing errors, and fitting directly into existing kitchen workflows and automatic pumping equipment. Bakery processes subject ingredients to high shear, heat, and complex aeration demands, making it a critical proving ground for alternative proteins where a single qualified functional replacement can be deployed across multiple bakery product lines such as rich doughs, cookies, cakes, and meringues.

Read source: Cultivated X